Find a Business Opportunity
Listing Number: 3921
$7.6m EBITDA Specialty Pharmacy (Confidential)
Project Meridian
$11.89m Gross Revenue
$7.5m EBITDA
Overview
Multi-site specialty pharmacy platform licensed in 14 states with integrated secondary fulfillment. The Company enjoys strong & stable financial performance, with consistent revenue and high operating margins.
The Company’s experienced management team has proven their operational expertise, and is willing to remain onboard. Each department has been built out to support the operation, offering complete coverage from onboarding and business development teams, through fulfillment, compliance, customer support and billing. Services include prescriptions, compounding, medication therapy management, home delivery, and clinical support. Multiple locations, with centralized fulfillment capabilities for other states.
Investment Highlights
Attractive Unit Economics: High gross margins and strong EBITDA conversion rates.
Diversified Revenue Streams: The Company is a leader in and maintains expertise in workflow, and processing for various types of patients, related to payors known for high reimbursements.
Diverse Referral Base: The Company receives referrals from 100s of Clinics in the region. No one referral source accounts for a large percentage of
Regulatory & Operational Moat: Multi-state licensure and HIPAA-compliant fulfillment operations.
Technology-Enabled Operations: Automated refill, synchronization, and next-day delivery systems.
Experienced Leadership: Management Team alone possesses over 80+ years combined pharmacy and healthcare management experience.
Full Revenue Cycle: Well established and currently at full revenue cycle.
Proven Scalability: Turnkey platform ready for add-on acquisitions and new market expansion.
CONFIDENTIAL SALE.
PROOF OF PORTFOLIO OR RELATED HEALTHCARE INDUSTRY / INVESTMENT BACKGROUND REQUIRED PRIOR TO RELEASE OF CONFIDENTIAL INFORMATION.
Listing Broker
Jonathan Barak
Business Intemediary Specialist
Phone: 954-596-8060
Email:
jbarak@capitalbbw.com
- Category: Health, Medical & Dental
- Asking Price: $0
- Gross Sales: $11,238,357
- Cash Flow: $7,577,566
- County: Confidential
- Area: Confidential
- FFE: $244,818
- Inventory: $234,758
- Real Estate: $0
- Employees: 12 - Full-Time 0 - Part-Time
- Facilities: Confidential
- Relocatable? No
- Home Based? No
- Market Notes: The North America non-sterile compounding pharmacy market is experiencing robust growth, driven by increasing demand for personalized medicine and chronic disease management. Valued at over USD 5.9 billion in 2024, the market is projected to reach over USD 10 billion by 2033 with a CAGR of roughly 6-7%, primarily dominated by the U.S. and oral/topical formulations.
- Growth Notes: Company has been stable and largely profitable since prior to COVID.
- Support Training: Management Team to remain onboard
- Year Established: 2018
- Financing Terms: Confidential
- Reason for Selling: Inquire with Broker
- Inventory Included: Yes
- Is Franchise No
- Lender Prequalified No
- Absentee Owner No
- Selling Financing? No
- Is FEE Included? Yes